Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

University of Kansas Medical Center1,000 enrolled

Overview

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Bladder Cancer

Interventions

RegistryOTHER

Patient registry

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate * Patients can participate in any additional research studies during the patients' participation within this protocol. Exclusion Criteria: * Patients who do not have presumed bladder cancer will not be eligible

Locations (1)

University of Kansas Medical Center

Kansas City, Kansas, United States

RECRUITING

Outcomes

Primary Outcomes

Blood, urine and tissue characteristics of bladder cancer patients

Samples will be collected over a 24 month period for patients to build a biorepository for future research on how they are related to tumor development, recurrence and survival.

Time frame: 24 months

Central Contacts

Jane Ladesma

CONTACT

913-588-8721 jledesma2@kumc.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.